Advertisement

Index by Author

January 1991; 40 (1)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Abbate, S L

    • Amount and speed of fast axonal transport in diabetes. Diabetes January 1991 40:111-117; doi:10.2337/diabetes.40.1.111

  2. Akanuma, Y

    • Comparison of 1,5-anhydroglucitol, HbA1c, and fructosamine for detection of diabetes mellitus. Diabetes January 1991 40:52-57; doi:10.2337/diabetes.40.1.52

  3. Andres, R

    • Age as independent determinant of glucose tolerance. Diabetes January 1991 40:44-51; doi:10.2337/diabetes.40.1.44

  4. Atkinson, M B

    • Amount and speed of fast axonal transport in diabetes. Diabetes January 1991 40:111-117; doi:10.2337/diabetes.40.1.111

B

  1. Baba, S

    • Comparison of 1,5-anhydroglucitol, HbA1c, and fructosamine for detection of diabetes mellitus. Diabetes January 1991 40:52-57; doi:10.2337/diabetes.40.1.52

  2. Barbetti, F

    • Normal coding sequence of insulin gene in Pima Indians and Nauruans, two groups with highest prevalence of type II diabetes. Diabetes January 1991 40:118-122; doi:10.2337/diabetes.40.1.118

  3. Barnett, A H

    • Clinical and neurophysiological studies of aldose reductase inhibitor ponalrestat in chronic symptomatic diabetic peripheral neuropathy. Diabetes January 1991 40:129-133; doi:10.2337/diabetes.40.1.129

  4. Bedoya, F J

    • Evolution of insulin secretory response to glucose by perifused islets from lean (FA/FA) rats chronically infused with glucose. Diabetes January 1991 40:7-14; doi:10.2337/diabetes.40.1.7
    • Insulin secretory response to secretagogues by perifused islets from chronically glucose-infused rats. Diabetes January 1991 40:15-19; doi:10.2337/diabetes.40.1.15

  5. Bengtsson, C

    • Low sex-hormone-binding globulin concentration as independent risk factor for development of NIDDM. 12-yr follow-up of population study of women in Gothenburg, Sweden. Diabetes January 1991 40:123-128; doi:10.2337/diabetes.40.1.123

  6. Bergman, R N

    • Importance of hepatic glucoreceptors in sympathoadrenal response to hypoglycemia. Diabetes January 1991 40:155-158; doi:10.2337/diabetes.40.1.155

  7. Bersch, N

    • Use of in vitro clonogenic assays to differentiate acquired from genetic causes of insulin resistance. Diabetes January 1991 40:28-36; doi:10.2337/diabetes.40.1.28

  8. Björntorp, P

    • Low sex-hormone-binding globulin concentration as independent risk factor for development of NIDDM. 12-yr follow-up of population study of women in Gothenburg, Sweden. Diabetes January 1991 40:123-128; doi:10.2337/diabetes.40.1.123

  9. Breuer, A C

    • Amount and speed of fast axonal transport in diabetes. Diabetes January 1991 40:111-117; doi:10.2337/diabetes.40.1.111

  10. Butler, P C

    • Contribution to postprandial hyperglycemia and effect on initial splanchnic glucose clearance of hepatic glucose cycling in glucose-intolerant or NIDDM patients. Diabetes January 1991 40:73-81; doi:10.2337/diabetes.40.1.73

C

  1. Cagliero, E

    • Characteristics and mechanisms of high-glucose-induced overexpression of basement membrane components in cultured human endothelial cells. Diabetes January 1991 40:102-110; doi:10.2337/diabetes.40.1.102

  2. Cama, A

    • Normal coding sequence of insulin gene in Pima Indians and Nauruans, two groups with highest prevalence of type II diabetes. Diabetes January 1991 40:118-122; doi:10.2337/diabetes.40.1.118

  3. Caro, J F

    • Immunolocalization of glucose transporter GLUT4 within human skeletal muscle. Diabetes January 1991 40:150-154; doi:10.2337/diabetes.40.1.150

  4. Chaffin, D G

    • Effects of fetal insulin deficiency on growth in fetal lambs. Diabetes January 1991 40:20-27; doi:10.2337/diabetes.40.1.20

  5. Clark, R M

    • Effects of fetal insulin deficiency on growth in fetal lambs. Diabetes January 1991 40:20-27; doi:10.2337/diabetes.40.1.20

  6. Cochrane, C

    • Control of expression of insulin resistance and hyperglycemia by different genetic factors in diabetic C57BL/6J mice. Diabetes January 1991 40:82-87; doi:10.2337/diabetes.40.1.82

D

  1. Dastvan, F

    • Effects of media conditions, insulin, and dexamethasone on insulin-receptor mRNA and promoter activity in HepG2 cells. Diabetes January 1991 40:58-65; doi:10.2337/diabetes.40.1.58

  2. Dohm, G L

    • Immunolocalization of glucose transporter GLUT4 within human skeletal muscle. Diabetes January 1991 40:150-154; doi:10.2337/diabetes.40.1.150

  3. Donovan, C M

    • Importance of hepatic glucoreceptors in sympathoadrenal response to hypoglycemia. Diabetes January 1991 40:155-158; doi:10.2337/diabetes.40.1.155

  4. Downes, D L

    • Immunolocalization of glucose transporter GLUT4 within human skeletal muscle. Diabetes January 1991 40:150-154; doi:10.2337/diabetes.40.1.150

  5. Dudek, R W

    • Immunolocalization of glucose transporter GLUT4 within human skeletal muscle. Diabetes January 1991 40:150-154; doi:10.2337/diabetes.40.1.150

F

  1. Feinglos, M N

    • Control of expression of insulin resistance and hyperglycemia by different genetic factors in diabetic C57BL/6J mice. Diabetes January 1991 40:82-87; doi:10.2337/diabetes.40.1.82

  2. Fleg, J L

    • Age as independent determinant of glucose tolerance. Diabetes January 1991 40:44-51; doi:10.2337/diabetes.40.1.44

  3. Florkowski, C M

    • Clinical and neurophysiological studies of aldose reductase inhibitor ponalrestat in chronic symptomatic diabetic peripheral neuropathy. Diabetes January 1991 40:129-133; doi:10.2337/diabetes.40.1.129

  4. Friedman, J E

    • Immunolocalization of glucose transporter GLUT4 within human skeletal muscle. Diabetes January 1991 40:150-154; doi:10.2337/diabetes.40.1.150

  5. Frisell, W R

    • Immunolocalization of glucose transporter GLUT4 within human skeletal muscle. Diabetes January 1991 40:150-154; doi:10.2337/diabetes.40.1.150

  6. Fritschy, W M

    • Effect of alginate-polylysine-alginate microencapsulation on in vitro insulin release from rat pancreatic islets. Diabetes January 1991 40:37-43; doi:10.2337/diabetes.40.1.37

G

  1. Geffner, M E

    • Use of in vitro clonogenic assays to differentiate acquired from genetic causes of insulin resistance. Diabetes January 1991 40:28-36; doi:10.2337/diabetes.40.1.28

  2. Glickman, P

    • Effects of media conditions, insulin, and dexamethasone on insulin-receptor mRNA and promoter activity in HepG2 cells. Diabetes January 1991 40:58-65; doi:10.2337/diabetes.40.1.58

  3. Golde, D W

    • Use of in vitro clonogenic assays to differentiate acquired from genetic causes of insulin resistance. Diabetes January 1991 40:28-36; doi:10.2337/diabetes.40.1.28

  4. Goldstein, S

    • Nutrition and somatomedin. XXIII. Molecular regulation of IGF-I by amino acid availability in cultured hepatocytes. Diabetes January 1991 40:95-101; doi:10.2337/diabetes.40.1.95

  5. Green, A

    • Evidence for impaired coupling of receptors to Gi protein in adipocytes from streptozocin-induced diabetic rats. Diabetes January 1991 40:88-94; doi:10.2337/diabetes.40.1.88

H

  1. Halter, J B

    • Importance of hepatic glucoreceptors in sympathoadrenal response to hypoglycemia. Diabetes January 1991 40:155-158; doi:10.2337/diabetes.40.1.155

  2. Harp, J B

    • Nutrition and somatomedin. XXIII. Molecular regulation of IGF-I by amino acid availability in cultured hepatocytes. Diabetes January 1991 40:95-101; doi:10.2337/diabetes.40.1.95

  3. Harvey, T C

    • Clinical and neurophysiological studies of aldose reductase inhibitor ponalrestat in chronic symptomatic diabetic peripheral neuropathy. Diabetes January 1991 40:129-133; doi:10.2337/diabetes.40.1.129

  4. Haymond, M W

    • Differential effects of prednisone and growth hormone on fuel metabolism and insulin antagonism in humans. Diabetes January 1991 40:141-149; doi:10.2337/diabetes.40.1.141

  5. Hiller, W F

    • Progressive deterioration of endocrine function after intraportal but not kidney subcapsular rat islet transplantation. Diabetes January 1991 40:134-140; doi:10.2337/diabetes.40.1.134

  6. Horber, F F

    • Differential effects of prednisone and growth hormone on fuel metabolism and insulin antagonism in humans. Diabetes January 1991 40:141-149; doi:10.2337/diabetes.40.1.141

J

  1. Jeanrenaud, B

    • Evolution of insulin secretory response to glucose by perifused islets from lean (FA/FA) rats chronically infused with glucose. Diabetes January 1991 40:7-14; doi:10.2337/diabetes.40.1.7
    • Insulin secretory response to secretagogues by perifused islets from chronically glucose-infused rats. Diabetes January 1991 40:15-19; doi:10.2337/diabetes.40.1.15

  2. Johnson, J L

    • Evidence for impaired coupling of receptors to Gi protein in adipocytes from streptozocin-induced diabetic rats. Diabetes January 1991 40:88-94; doi:10.2337/diabetes.40.1.88

  3. Johnson, N B

    • Use of in vitro clonogenic assays to differentiate acquired from genetic causes of insulin resistance. Diabetes January 1991 40:28-36; doi:10.2337/diabetes.40.1.28

K

  1. Kahn, C R

    • Coordinate phosphorylation of insulin-receptor kinase and its 175,000-Mr endogenous substrate in rat hepatocytes. Diabetes January 1991 40:66-72; doi:10.2337/diabetes.40.1.66

  2. Kanazawa, Y

    • Comparison of 1,5-anhydroglucitol, HbA1c, and fructosamine for detection of diabetes mellitus. Diabetes January 1991 40:52-57; doi:10.2337/diabetes.40.1.52

  3. Karasik, A

    • Coordinate phosphorylation of insulin-receptor kinase and its 175,000-Mr endogenous substrate in rat hepatocytes. Diabetes January 1991 40:66-72; doi:10.2337/diabetes.40.1.66

  4. Kawai, T

    • Comparison of 1,5-anhydroglucitol, HbA1c, and fructosamine for detection of diabetes mellitus. Diabetes January 1991 40:52-57; doi:10.2337/diabetes.40.1.52

  5. Kawazu, S

    • Comparison of 1,5-anhydroglucitol, HbA1c, and fructosamine for detection of diabetes mellitus. Diabetes January 1991 40:52-57; doi:10.2337/diabetes.40.1.52

  6. Klempnauer, J

    • Progressive deterioration of endocrine function after intraportal but not kidney subcapsular rat islet transplantation. Diabetes January 1991 40:134-140; doi:10.2337/diabetes.40.1.134

  7. Knox, I

    • Effects of fetal insulin deficiency on growth in fetal lambs. Diabetes January 1991 40:20-27; doi:10.2337/diabetes.40.1.20

  8. Krystal, G

    • Effects of media conditions, insulin, and dexamethasone on insulin-receptor mRNA and promoter activity in HepG2 cells. Diabetes January 1991 40:58-65; doi:10.2337/diabetes.40.1.58

  9. Kuhn, C M

    • Control of expression of insulin resistance and hyperglycemia by different genetic factors in diabetic C57BL/6J mice. Diabetes January 1991 40:82-87; doi:10.2337/diabetes.40.1.82

  10. Kuzuya, T

    • Comparison of 1,5-anhydroglucitol, HbA1c, and fructosamine for detection of diabetes mellitus. Diabetes January 1991 40:52-57; doi:10.2337/diabetes.40.1.52

L

  1. Lapidus, L

    • Low sex-hormone-binding globulin concentration as independent risk factor for development of NIDDM. 12-yr follow-up of population study of women in Gothenburg, Sweden. Diabetes January 1991 40:123-128; doi:10.2337/diabetes.40.1.123

  2. Lesniak, M A

    • Normal coding sequence of insulin gene in Pima Indians and Nauruans, two groups with highest prevalence of type II diabetes. Diabetes January 1991 40:118-122; doi:10.2337/diabetes.40.1.118

  3. Levy, J R

    • Effects of media conditions, insulin, and dexamethasone on insulin-receptor mRNA and promoter activity in HepG2 cells. Diabetes January 1991 40:58-65; doi:10.2337/diabetes.40.1.58

  4. Lillioja, S

    • Normal coding sequence of insulin gene in Pima Indians and Nauruans, two groups with highest prevalence of type II diabetes. Diabetes January 1991 40:118-122; doi:10.2337/diabetes.40.1.118

  5. Lindstedt, G

    • Low sex-hormone-binding globulin concentration as independent risk factor for development of NIDDM. 12-yr follow-up of population study of women in Gothenburg, Sweden. Diabetes January 1991 40:123-128; doi:10.2337/diabetes.40.1.123

  6. Lorenzi, M

    • Characteristics and mechanisms of high-glucose-induced overexpression of basement membrane components in cultured human endothelial cells. Diabetes January 1991 40:102-110; doi:10.2337/diabetes.40.1.102

  7. Lück, R

    • Progressive deterioration of endocrine function after intraportal but not kidney subcapsular rat islet transplantation. Diabetes January 1991 40:134-140; doi:10.2337/diabetes.40.1.134

  8. Lundberg, P A

    • Low sex-hormone-binding globulin concentration as independent risk factor for development of NIDDM. 12-yr follow-up of population study of women in Gothenburg, Sweden. Diabetes January 1991 40:123-128; doi:10.2337/diabetes.40.1.123

  9. Lundgren, H

    • Low sex-hormone-binding globulin concentration as independent risk factor for development of NIDDM. 12-yr follow-up of population study of women in Gothenburg, Sweden. Diabetes January 1991 40:123-128; doi:10.2337/diabetes.40.1.123

M

  1. Marsh, H M

    • Differential effects of prednisone and growth hormone on fuel metabolism and insulin antagonism in humans. Diabetes January 1991 40:141-149; doi:10.2337/diabetes.40.1.141

  2. Muller, D C

    • Age as independent determinant of glucose tolerance. Diabetes January 1991 40:44-51; doi:10.2337/diabetes.40.1.44

N

  1. Nakamoto, J M

    • Use of in vitro clonogenic assays to differentiate acquired from genetic causes of insulin resistance. Diabetes January 1991 40:28-36; doi:10.2337/diabetes.40.1.28

  2. Nightingale, S

    • Clinical and neurophysiological studies of aldose reductase inhibitor ponalrestat in chronic symptomatic diabetic peripheral neuropathy. Diabetes January 1991 40:129-133; doi:10.2337/diabetes.40.1.129

O

  1. Ohta, M

    • Comparison of 1,5-anhydroglucitol, HbA1c, and fructosamine for detection of diabetes mellitus. Diabetes January 1991 40:52-57; doi:10.2337/diabetes.40.1.52

  2. Okamoto, M

    • Coordinate phosphorylation of insulin-receptor kinase and its 175,000-Mr endogenous substrate in rat hepatocytes. Diabetes January 1991 40:66-72; doi:10.2337/diabetes.40.1.66

P

  1. Philipps, A F

    • Effects of fetal insulin deficiency on growth in fetal lambs. Diabetes January 1991 40:20-27; doi:10.2337/diabetes.40.1.20

  2. Phillips, L S

    • Nutrition and somatomedin. XXIII. Molecular regulation of IGF-I by amino acid availability in cultured hepatocytes. Diabetes January 1991 40:95-101; doi:10.2337/diabetes.40.1.95

R

  1. Raben, N

    • Normal coding sequence of insulin gene in Pima Indians and Nauruans, two groups with highest prevalence of type II diabetes. Diabetes January 1991 40:118-122; doi:10.2337/diabetes.40.1.118

  2. Raye, J R

    • Effects of fetal insulin deficiency on growth in fetal lambs. Diabetes January 1991 40:20-27; doi:10.2337/diabetes.40.1.20

  3. Rizza, R A

    • Contribution to postprandial hyperglycemia and effect on initial splanchnic glucose clearance of hepatic glucose cycling in glucose-intolerant or NIDDM patients. Diabetes January 1991 40:73-81; doi:10.2337/diabetes.40.1.73

  4. Robertson, R P

    • G proteins and modulation of insulin secretion. Diabetes January 1991 40:1-6; doi:10.2337/diabetes.40.1.1

  5. Rosenkrantz, T S

    • Effects of fetal insulin deficiency on growth in fetal lambs. Diabetes January 1991 40:20-27; doi:10.2337/diabetes.40.1.20

  6. Roth, J

    • Normal coding sequence of insulin gene in Pima Indians and Nauruans, two groups with highest prevalence of type II diabetes. Diabetes January 1991 40:118-122; doi:10.2337/diabetes.40.1.118

  7. Roth, T

    • Characteristics and mechanisms of high-glucose-induced overexpression of basement membrane components in cultured human endothelial cells. Diabetes January 1991 40:102-110; doi:10.2337/diabetes.40.1.102

  8. Rowe, B R

    • Clinical and neurophysiological studies of aldose reductase inhibitor ponalrestat in chronic symptomatic diabetic peripheral neuropathy. Diabetes January 1991 40:129-133; doi:10.2337/diabetes.40.1.129

  9. Roy, S

    • Characteristics and mechanisms of high-glucose-induced overexpression of basement membrane components in cultured human endothelial cells. Diabetes January 1991 40:102-110; doi:10.2337/diabetes.40.1.102

S

  1. Scott, M

    • Use of in vitro clonogenic assays to differentiate acquired from genetic causes of insulin resistance. Diabetes January 1991 40:28-36; doi:10.2337/diabetes.40.1.28

  2. Seaquist, E R

    • G proteins and modulation of insulin secretion. Diabetes January 1991 40:1-6; doi:10.2337/diabetes.40.1.1

  3. Seldin, M F

    • Control of expression of insulin resistance and hyperglycemia by different genetic factors in diabetic C57BL/6J mice. Diabetes January 1991 40:82-87; doi:10.2337/diabetes.40.1.82

  4. Serjeantson, S W

    • Normal coding sequence of insulin gene in Pima Indians and Nauruans, two groups with highest prevalence of type II diabetes. Diabetes January 1991 40:118-122; doi:10.2337/diabetes.40.1.118

  5. Shimokata, H

    • Age as independent determinant of glucose tolerance. Diabetes January 1991 40:44-51; doi:10.2337/diabetes.40.1.44

  6. Sorkin, J

    • Age as independent determinant of glucose tolerance. Diabetes January 1991 40:44-51; doi:10.2337/diabetes.40.1.44

  7. Steiniger, B

    • Progressive deterioration of endocrine function after intraportal but not kidney subcapsular rat islet transplantation. Diabetes January 1991 40:134-140; doi:10.2337/diabetes.40.1.134

  8. Surwit, R S

    • Control of expression of insulin resistance and hyperglycemia by different genetic factors in diabetic C57BL/6J mice. Diabetes January 1991 40:82-87; doi:10.2337/diabetes.40.1.82

T

  1. Taylor, S I

    • Normal coding sequence of insulin gene in Pima Indians and Nauruans, two groups with highest prevalence of type II diabetes. Diabetes January 1991 40:118-122; doi:10.2337/diabetes.40.1.118

  2. Toyota, T

    • Comparison of 1,5-anhydroglucitol, HbA1c, and fructosamine for detection of diabetes mellitus. Diabetes January 1991 40:52-57; doi:10.2337/diabetes.40.1.52

V

  1. van Schilfgaarde, R

    • Effect of alginate-polylysine-alginate microencapsulation on in vitro insulin release from rat pancreatic islets. Diabetes January 1991 40:37-43; doi:10.2337/diabetes.40.1.37

W

  1. Walseth, T F

    • G proteins and modulation of insulin secretion. Diabetes January 1991 40:1-6; doi:10.2337/diabetes.40.1.1

  2. Whitehead, D S

    • Immunolocalization of glucose transporter GLUT4 within human skeletal muscle. Diabetes January 1991 40:150-154; doi:10.2337/diabetes.40.1.150

  3. White, M F

    • Coordinate phosphorylation of insulin-receptor kinase and its 175,000-Mr endogenous substrate in rat hepatocytes. Diabetes January 1991 40:66-72; doi:10.2337/diabetes.40.1.66

  4. Wolters, G H

    • Effect of alginate-polylysine-alginate microencapsulation on in vitro insulin release from rat pancreatic islets. Diabetes January 1991 40:37-43; doi:10.2337/diabetes.40.1.37

Y

  1. Yamanouchi, T

    • Comparison of 1,5-anhydroglucitol, HbA1c, and fructosamine for detection of diabetes mellitus. Diabetes January 1991 40:52-57; doi:10.2337/diabetes.40.1.52

  2. Yoshioka, S

    • Comparison of 1,5-anhydroglucitol, HbA1c, and fructosamine for detection of diabetes mellitus. Diabetes January 1991 40:52-57; doi:10.2337/diabetes.40.1.52

Z

  1. Ziemba, A W

    • Age as independent determinant of glucose tolerance. Diabetes January 1991 40:44-51; doi:10.2337/diabetes.40.1.44

  2. Zimmet, P

    • Normal coding sequence of insulin gene in Pima Indians and Nauruans, two groups with highest prevalence of type II diabetes. Diabetes January 1991 40:118-122; doi:10.2337/diabetes.40.1.118

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement